Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants-Reference-Cited by-同舟云学术

Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants

Published:2016-07-07 Issue:10 Volume:36 Page:837-848
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Yamaji Hirosuke^ORCID,Murakami Takashi,Hina Kazuyoshi,Higashiya Shunich,Kawamura Hiroshi,Murakami Masaaki,Kamikawa Shigeshi,Komtasubara Issei,Kusachi Shozo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-016-0435-6.pdf

Reference30 articles.

1. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–52.

2. Seshadri N, Marrouche NF, Wilber D, Packer D, Natale A. Pulmonary vein isolation for treatment of atrial fibrillation: recent updates. Pacing Clin Electrophysiol. 2003;26:1636–40.

3. Yamane T, Date T, Kanzaki Y, Inada K, Matsuo S, Shibayama K, Miyanaga S, Miyazaki H, Sugimoto K, Mochizuki S. Segmental pulmonary vein antrum isolation using the “large-size” lasso catheter in patients with atrial fibrillation. Circ J. 2007;71:753–60.

4. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Europace. 2007;9:335–79.

5. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100–5.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Nomogram Model Affecting the ACT Targeting Rate During Radiofrequency Ablation of Atrial Fibrillation in China;Cardiovascular Drugs and Therapy;2023-05-09

2. Safety of a single bolus administration of heparin without the measurement of activated clotting time during cryoballoon ablation: a prospective randomized controlled trial;Journal of Interventional Cardiac Electrophysiology;2022-08-31

3. Effect of uninterrupted dabigatran or rivaroxaban on achieving ideal activated clotting time to heparin response during catheter ablation in patients with atrial fibrillation;J GERIATR CARDIOL;2022

4. Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation;Journal of Arrhythmia;2021-11-19

5. Comparison of uninterrupted direct oral anticoagulation with vitamin‐K antagonists during AF ‐ablation in the clinical routine. A single center register;Clinical Cardiology;2021-07-26